Skip to main content
HR 5281 116th Congress House Health Business records Congressional oversight Government information and archives Health care costs and insurance Home and outpatient care Inflation and prices Medicaid Prescription drugs Public contracts and procurement Retail and wholesale trades State and local government operations User charges and fees

Drug Price Transparency in Medicaid Act of 2019

Introduced: December 3, 2019 Introduced by: Carter, Earl L. "Buddy" Republican · Georgia See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 4, 2019
Referred to the Subcommittee on Health.
Dec 3, 2019
Referred to the House Committee on Energy and Commerce.
Dec 3, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Drug Price Transparency in Medicaid Act of 2019

This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions, dispensing fees, and survey participation to be made publicly available.

What's happening now December 4, 2019

Referred to the Subcommittee on Health.

 Related & companion bills 4
  • HR 3 Related bill Elijah E. Cummings Lower Drug Costs Now Act
  • HR 19 Related bill Lower Costs, More Cures Act of 2019
  • S 2543 Related bill Prescription Drug Pricing Reduction Act of 2019
  • S 4199 Related bill Prescription Drug Pricing Reduction Act of 2020
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5281: Drug Price Transparency in Medicaid Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-5281/
MLA
"H.R. 5281: Drug Price Transparency in Medicaid Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-5281/.
Bluebook (legal)
H.R. 5281, 116th Cong. (2026), https://openamerica.io/bill/116-HR-5281/.
Markdown link
[H.R. 5281: Drug Price Transparency in Medicaid Act of 2019](https://openamerica.io/bill/116-HR-5281/)
Report a problem